News Image
CNBCTV18

Shaily Engineering bags ₹423 crore pen injector supply deal

Published on 25/02/2026 05:14 PM

Shaily Engineering bags ₹423 crore pen injector supply dealShaily Engineering Plastics secured a ₹423 crore pen injector supply deal. Shares of Shaily Engineering Plastics ended marginally lower on Wednesday, February 25, by 0.21% at ₹1,941.50 on the NSE.By CNBCTV18February 25, 2026, 5:14:10 PM IST (Published)2 Min Read

Shaily Engineering Plastics has secured a manufacturing and commercial supply agreement worth approximately ₹423 crore from a large domestic pharmaceutical company for the supply of pen injectors.

The customer’s name has not been disclosed due to confidentiality reasons, stated the exchange filing. The order has been awarded by a domestic entity and involves the manufacturing and commercial supply of pen injectors over a period of four years.

The company clarified in the filing that neither the promoter nor the promoter group has any interest in the awarding entity. It also stated that the contract does not fall under related party transactions.

Recently, the company announced the appointment of Joe Kam as Chief Operating Officer (Healthcare), effective March 1, 2026.

Kam brings over two decades of international experience in manufacturing and operations across highly regulated and process-driven industries. Prior to joining Shaily, he held senior leadership roles at SHL Medical, most recently serving as Senior Manufacturing Director responsible for nine manufacturing sites across Taiwan and the US. He has also worked at Flextronics as Plant Manager and Senior Project Manager.

He holds an Executive MBA from The Chinese University of Hong Kong, along with advanced academic qualifications in Automation Systems and Engineering Management.

In its quarter results, the company said it plans to set up a medical devices manufacturing facility in Abu Dhabi with an investment of AED 130–150 million. The proposed facility will have an annual capacity of around 75 million pen injectors and is expected to become operational by the fourth quarter of FY28, the filing added.

Shares of Shaily Engineering Plastics ended marginally lower on Wednesday, February 25, by 0.21% at ₹1,941.50 on the NSE.

Also Read: Tata Capital arm Tata Capital Housing Finance to raise ₹650 crore via rights issueContinue ReadingTagsmanufacturingMedical devicesorder winpharmaceutical